Publications en collaboration avec des chercheurs de Fundación Jiménez Díaz (16)

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

2023

  1. Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections

    Frontiers in Medicine, Vol. 10

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

2020

  1. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

2018

  1. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38

  2. Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment

    Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337

2012

  1. Factores sociodemográficos asociados a la progresión de la infección por VIH e impacto del TARGA en una cohorte de pacientes seroconvertores en Madrid (1986-2009)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 3, pp. 117-123

2008

  1. High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain

    Clinical Chemistry and Laboratory Medicine, Vol. 46, Núm. 6, pp. 809-813

  2. Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens

    HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313

2007

  1. Análisis de la actividad paraoxonasa (PON1) y de los polimorfismos PON1 192 y PON1 55 en la población prepuberal del Estudio Cuatro Provincias

    Clinica e Investigacion en Arteriosclerosis, Vol. 19, Núm. 6, pp. 287-292

2004

  1. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients

    Journal of Antimicrobial Chemotherapy, Vol. 53, Núm. 3, pp. 540-543

2003

  1. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: A randomized pilot study

    Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 3, pp. 464-468

2002

  1. Dietary patterns among children aged 6-7 y in four Spanish cities with widely differing cardiovascular mortality

    European Journal of Clinical Nutrition, Vol. 56, Núm. 2, pp. 141-148

  2. Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999

    Sexually Transmitted Infections, Vol. 78, Núm. 4, pp. 255-260

  3. Influence of birth weight on the apo E genetic determinants of plasma lipid levels in children

    Pediatric Research, Vol. 52, Núm. 6, pp. 873-878

  4. Metabolic factors in school children population associated with adult cardiovascular mortality. Four provinces study

    Medicina Clinica, Vol. 118, Núm. 20, pp. 767-770